Workflow
UiPath(PATH)
icon
Search documents
UiPath(PATH) - 2025 Q3 - Quarterly Results
2024-12-05 21:14
UiPath Reports Third Quarter Fiscal 2025 Financial Results Revenue of $355 million increases 9 percent year-over-year ARR of $1.607 billion increases 17 percent year-over-year NEW YORK, NY – December 5, 2024 – UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced financial results for its third quarter fiscal 2025 ended October 31, 2024. "Our customers' response to the agentic automation vision and roadmap that we announced at FORWARD has been energizing and rei ...
Should You Buy, Sell, or Hold UiPath Stock Before Q3 Earnings?
ZACKS· 2024-12-04 21:01
UiPath Inc. (PATH) will report its third-quarter fiscal 2025 results on Thursday, after the bell.The Zacks Consensus Estimate for earnings in the to-be-reported quarter stands at 7 cents, indicating a 41.7% decline from the year-ago reported quarter. The consensus estimate for revenues stands at $347.6 million, implying 6.7% year-over-year growth. There has been no change in analyst estimates or revisions lately.Image Source: Zacks Investment ResearchThe company has an impressive earnings surprise history. ...
What Analyst Projections for Key Metrics Reveal About UiPath (PATH) Q3 Earnings
ZACKS· 2024-12-02 19:30
Analysts on Wall Street project that UiPath (PATH) will announce quarterly earnings of $0.07 per share in its forthcoming report, representing a decline of 41.7% year over year. Revenues are projected to reach $347.61 million, increasing 6.7% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's e ...
UiPath: The Hidden Gem In Robotic Process Automation Worth Buying Now
Seeking Alpha· 2024-11-19 04:16
The company was in disarray when I last wrote about UiPath (NYSE: PATH ). Its chief Executive Officer ("CEO") and board member, Rob Enslin, suddenly resigned amid the company giving poor revenue and operating margin guidance for fiscal year ("FY") 2025 in its first quarterI have been a Merchant Seaman that has traveled the world for over 30 years. Within the last 15 years, I developed a very intense interest in investing. I learned a lot of what I know about investing from The MF. Also because I have a engi ...
UiPath: Will Become A Different Company
Seeking Alpha· 2024-11-17 06:08
My first article on UiPath Inc. (NYSE: PATH ) , titled: UiPath has the Potential to have a very deep Moat , was published in March 2023 when the stock was trading at ~$16. Then, as now, IMy primary area of concentration will be on identifying companies of exceptional caliber, with a proven ability to reinvest capital for impressive returns. Targeting those with a market capitalization of less than $10 billion, affords ample opportunities for growth. The ideal scenario is for these companies to demonstrate a ...
UiPath (PATH) Rises Higher Than Market: Key Facts
ZACKS· 2024-11-13 23:45
UiPath (PATH) ended the recent trading session at $13.53, demonstrating a +1.27% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.02%. At the same time, the Dow added 0.11%, and the tech-heavy Nasdaq lost 0.26%.Shares of the enterprise automation software developer witnessed a gain of 3.81% over the previous month, trailing the performance of the Business Services sector with its gain of 8.97% and outperforming the S&P 500's gain of 2.99%.Investors ...
UiPath (PATH) Outperforms Broader Market: What You Need to Know
ZACKS· 2024-11-07 23:51
UiPath (PATH) closed the most recent trading day at $13.38, moving +1.75% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.74%.The enterprise automation software developer's shares have seen an increase of 5.71% over the last month, not keeping up with the Business Services sector's gain of 9.12% and outstripping the S&P 500's gain of 3.16%.Investors will be eagerly watching for the performance of UiPath in its upcoming earnings disclosure. The company's earn ...
FEDERAL CONTRACEPTION PROPOSAL TO EXPAND ACCESS AND AFFORDABLE COVERAGE PAVES A STRONGER PATH FOR MAYNE PHARMA'S GROWTH IN WOMEN'S HEALTH
Prnewswire· 2024-11-04 13:00
Proposed Ruling Aims to Eliminate Out-of-Pocket Costs for Contraception, Enhancing Access for Women in the United StatesADELAIDE, Australia and RALEIGH, N.C., Nov. 4, 2024 /PRNewswire/ -- Mayne Pharma Group Limited (Mayne Pharma or the Company) (ASX: MYX), welcomes the Biden-Harris Administration's newly proposed rule to expand coverage of affordable contraception under the Affordable Care Act (ACA). The proposal aims to significantly increase coverage of contraception for the 52 million US women of reprodu ...
UiPath: Buy For Strong Recovery Potential, Future Enterprise AI Growth
Seeking Alpha· 2024-10-28 18:25
Gartner just released a forecast for the global IT spending in 2025. There will be a 9.3% increase from 2024, which is quite significant because this increase is higher than the 8% increase estimated for 2024. So it tells us that Advanced education in economics, business management and engineering. Professional experience with product management and development in high tech industry, including advisory with multiple fintech startups. Have been investing in growth companies since 1998. Recent interest of inv ...
Buy the Dip? UiPath Stock's GenAI Strategy May Pay Off
MarketBeat· 2024-10-18 13:50
UiPath Today PATH UiPath $13.00 +0.23 (+1.80%) 52-Week Range $10.37 ▼ $27.87 Price Target $17.71 Add to Watchlist UiPath NYSE: PATH is at the forefront of the enterprise automation software sector, providing powerful tools that enable businesses to automate repetitive tasks, streamline workflows, and boost overall efficiency. However, UiPath's stock price is down close to 50% year to date, which has left many investors wondering if this is a buying opportunity or a sign of further decline. The company is cu ...